The DOI matches its Crossref record; 151 of the 151 references it cites were found in a registry or an index.
Cellular Plasticity Cascades: Targets for the Development of Novel Therapeutics for Bipolar Disorder
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epigenetic programming by maternal behavior
Weaver, I. C. G., Cervoni, N., Champagne, F. A., D'Alessio, A. C., Sharma, S., Seckl, J. R., Dymov, S., Szyf, M., & Meaney, M. J. (2004) · Nature Neuroscience · doi:10.1038/nn1276 · Cited by 6,177
Antidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856
Nestler, E. J., Barrot, M., DiLeone, R. J., Eisch, A. J., Gold, S. J., & Monteggia, L. M. (2002) · Neuron · doi:10.1016/s0896-6273(02)00653-0 · Cited by 3,217
A molecular mechanism for the effect of lithium on development.
Klein, P. S., & Melton, D. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8455 · Cited by 2,301
A molecular and cellular theory of depression
Duman, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190015002 · Cited by 2,129
STRESS AND HIPPOCAMPAL PLASTICITY
McEwen, B. S. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.105 · Cited by 2,087
GSK-3: tricks of the trade for a multi-tasking kinase
Doble, B. W., & Woodgett, J. R. (2003) · Journal of Cell Science · doi:10.1242/jcs.00384 · Cited by 2,084
Memantine in Moderate-to-Severe Alzheimer's Disease
Reisberg, B., Doody, R., Stöffler, A., Schmitt, F., Ferris, S., & Möbius, H. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa013128 · Cited by 2,043
Glucocorticoids and Hippocampal Atrophy in Neuropsychiatric Disorders
Sapolsky, R. M. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.10.925 · Cited by 2,016
Ca2+ Influx Regulates BDNF Transcription by a CREB Family Transcription Factor-Dependent Mechanism
Tao, X., Finkbeiner, S., Arnold, D. B., Shaywitz, A. J., & Greenberg, M. E. (1998) · Neuron · doi:10.1016/s0896-6273(00)81010-7 · Cited by 1,561
Glial reduction in the subgenual prefrontal cortex in mood disorders
Öngür, D., Drevets, W. C., & Price, J. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13290 · Cited by 1,525 · cited 1×
“…glial cells in these regions may contribute to mpairments of neuronal structural plasticity by reducing the euron’s energy supply and reduced glial-mediated clearing of xcessive synaptic glutamate (Coyle and Schwarcz 2000; Haydon 001; Ongur et al 1998; Rajkowska 2000; Rajkowska et al 1999; igure 3.”
BackgroundRajkowska, G., Miguel-Hidalgo, J. J., Wei, J., Dilley, G., Pittman, S. D., Meltzer, H. Y., Overholser, J. C., Roth, B. L., & Stockmeier, C. A. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00041-4 · Cited by 1,477 · cited 1×
“…glial cells in these regions may contribute to mpairments of neuronal structural plasticity by reducing the euron’s energy supply and reduced glial-mediated clearing of xcessive synaptic glutamate (Coyle and Schwarcz 2000; Haydon 001; Ongur et al 1998; Rajkowska 2000; Rajkowska et al 1999; igure 3.”
BackgroundGlia: listening and talking to the synapse
Haydon, P. G. (2001) · Nature Reviews Neuroscience · doi:10.1038/35058528 · Cited by 1,408
Control of Synapse Number by Glia
Ullian, E. M., Sapperstein, S. K., Christopherson, K. S., & Barres, B. A. (2001) · Science · doi:10.1126/science.291.5504.657 · Cited by 1,380
Nibuya, M., Nestler, E., & Duman, R. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-07-02365.1996 · Cited by 1,206
GSK-3α regulates production of Alzheimer's disease amyloid-β peptides
Phiel, C. J., Wilson, C. A., Lee, V. M.-Y., & Klein, P. S. (2003) · Nature · doi:10.1038/nature01640 · Cited by 1,196
McShane, R., Areosa Sastre, A., & Minakaran, N. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003154.pub5 · Cited by 1,155
Drevets, W. C. (2001) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00203-8 · Cited by 1,146 · cited 1×
“Such circuits are thought to support the behavioral and visceral manifestations of mood disorders (Drevets 2001; Nestler et al 2002).”
BackgroundCalabrese, J. R., Bowden, C. L., Sachs, G. S., Ascher, J. A., Monaghan, E., Rudd, G. D., & The Lamictal 602 Study Group (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0203 · Cited by 1,054
Glutamate receptor function in learning and memory
Riedel, G. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00272-3 · Cited by 962
CREB: A Major Mediator of Neuronal Neurotrophin Responses
Finkbeiner, S., Tavazoie, S. F., Maloratsky, A., Jacobs, K. M., Harris, K. M., & Greenberg, M. E. (1997) · Neuron · doi:10.1016/s0896-6273(00)80395-5 · Cited by 949
Hockly, E., Richon, V. M., Woodman, B., Smith, D. L., Zhou, X., Rosa, E., Sathasivam, K., Ghazi-Noori, S., Mahal, A., Lowden, P. A. S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0437870100 · Cited by 845
CBP Histone Acetyltransferase Activity Is a Critical Component of Memory Consolidation
Korzus, E., Rosenfeld, M. G., & Mayford, M. (2004) · Neuron · doi:10.1016/j.neuron.2004.06.002 · Cited by 823
Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells
Rajkowska, G. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00950-1 · Cited by 822
Teyler, T. J., & DiScenna, P. (1987) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.10.030187.001023 · Cited by 788
Metabotropic glutamate receptors: electrophysiological properties and role in plasticity
Anwyl, R. (1999) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00050-2 · Cited by 780
Cotter, D., Mackay, D., Landau, S., Kerwin, R., & Everall, I. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.6.545 · Cited by 766
Cameron, H., McEwen, B., & Gould, E. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-06-04687.1995 · Cited by 741
Zobel, A. W., Nickel, T., Künzel, H. E., Ackl, N., Sonntag, A., Ising, M., & Holsboer, F. (2000) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(00)00016-9 · Cited by 705
Ferrante, R. J., Kubilus, J. K., Lee, J., Ryu, H., Beesen, A., Zucker, B., Smith, K., Kowall, N. W., Ratan, R. R., Luthi-Carter, R., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-28-09418.2003 · Cited by 693
Schoepp, D. D. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29296-x · Cited by 690
Lithium-induced increase in human brain grey matter
Moore, G. J., Bebchuk, J. M., Wilds, I. B., Chen, G., & Menji, H. K. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02793-8 · Cited by 649 · cited 2×
“Four weeks f lithium treatment produced a significant increase in NAA evels, effects that were localized almost exclusively to gray atter (Moore et al 2000).”
BackgroundMetabotropic glutamate receptors
Ferraguti, F., & Shigemoto, R. (2006) · Cell and Tissue Research · doi:10.1007/s00441-006-0266-5 · Cited by 640
Enhancement of Hippocampal Neurogenesis by Lithium
Chen, G., Rajkowska, G., Du, F., Seraji‐Bozorgzad, N., & Manji, H. K. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751729.x · Cited by 599
Self-citationDistinct components of spatial learning revealed by prior training and NMDA receptor blockade
Bannerman, D. M., Good, M. A., Butcher, S. P., Ramsay, M., & Morris, R. G. M. (1995) · Nature · doi:10.1038/378182a0 · Cited by 551 · cited 1×
“…roles including mediating neurotransmission across excitatory synapses and regulating numerous physiologic functions in the mammalian CNS such as synaptic plasticity, learning, and memory (Bannerman et al 1995; Collingridge 1994; Collingridge and Bliss 1995; Watkins and Collingridge 1994).”
BackgroundLeach, M. J., Marden, C. M., & Miller, A. A. (1986) · Epilepsia · doi:10.1111/j.1528-1157.1986.tb03573.x · Cited by 549
Orgogozo, J.-M., Rigaud, A.-S., Stöffler, A., Möbius, H.-J., & Forette, F. (2002) · Stroke · doi:10.1161/01.str.0000020094.08790.49 · Cited by 539
Antidepressants and neuroplasticity
D'Sa, C., & Duman, R. S. (2002) · Bipolar Disorders · doi:10.1034/j.1399-5618.2002.01203.x · Cited by 513
Manji, H. K., Quiroz, J. A., Sporn, J., Payne, J. L., Denicoff, K., A. Gray, N., Zarate, C. A., & Charney, D. S. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00117-3 · Cited by 505
Self-citationChen, G., Zeng, W., Yuan, P., Huang, L., Jiang, Y., Zhao, Z., & Manji, H. K. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.720879.x · Cited by 494
Self-citationCLINICAL DEVELOPMENT OF HISTONE DEACETYLASE INHIBITORS AS ANTICANCER AGENTS
Drummond, D. C., Noble, C. O., Kirpotin, D. B., Guo, Z., Scott, G. K., & Benz, C. C. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095825 · Cited by 494
The Increasing Medical Burden in Bipolar Disorder
Kupfer, D. J. (2005) · JAMA · doi:10.1001/jama.293.20.2528 · Cited by 489
Memories of NMDA receptors and LTP
Collingridge, G. L., & Bliss, T. V. P. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)80016-u · Cited by 488
The McLean-Harvard First-Episode Mania Study: Prediction of Recovery and First Recurrence
Tohen, M., Zarate, C. A., Hennen, J., Khalsa, H.-M. K., Strakowski, S. M., Gebre-Medhin, P., Salvatore, P., & Baldessarini, R. J. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.12.2099 · Cited by 471
Self-citationLong Term Lithium Treatment Suppresses p53 and Bax Expression but Increases Bcl-2 Expression
Chen, R.-W., & Chuang, D.-M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6039 · Cited by 469
Neuroplasticity Failure in Alzheimer's Disease
Mesulam, M.-M. (1999) · Neuron · doi:10.1016/s0896-6273(00)81109-5 · Cited by 449 · cited 1×
“…P p f v anifestations of neuroplasticity in the adult CNS have been haracterized as including alterations of dendritic function, synptic remodeling, long-term potentiation (LTP), axonal sproutng, neurite extension, synaptogenesis, and even neurogenesis for an excellent overview, see Mesulam 1999).”
BackgroundMetabotropic glutamate receptors: a new target for the therapy of neurodegenerative disorders?
Nicoletti, F., Bruno, V., Copani, A., Casabona, G., & Knöpfel, T. (1996) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)20019-0 · Cited by 433
Dysregulation of the fibroblast growth factor system in major depression
Evans, S. J., Choudary, P. V., Neal, C. R., Li, J. Z., Vawter, M. P., Tomita, H., Lopez, J. F., Thompson, R. C., Meng, F., Stead, J. D., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406788101 · Cited by 424
Inhibition of N-acetylaspartate production: implications for 1H MRS studies in vivo.
Bates, T. E., Strangward, M., Keelan, J., Davey, G. P., Munro, P., & Clark, J. B. (1996) · PubMed · Cited by 422
N -Acetylaspartate in neuropsychiatric disorders
Tsai, G., & Coyle, J. T. (1995) · Progress in Neurobiology · doi:10.1016/0301-0082(95)00014-m · Cited by 422
Wilson, B. E., Mochon, E., & Boxer, L. M. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.10.5546 · Cited by 410
Habib, K. E., Weld, K. P., Rice, K. C., Pushkas, J., Champoux, M., Listwak, S., Webster, E. L., Atkinson, A. J., Schulkin, J., Contoreggi, C., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.11.6079 · Cited by 403
Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders
Holmes, A., Heilig, M., Rupniak, N. M. J., Steckler, T., & Griebel, G. (2003) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2003.09.011 · Cited by 403
Moore, G. J., Bebchuk, J. M., Hasanat, K., Chen, G., Seraji-Bozorgzad, N., Wilds, I. B., Faulk, M. W., Koch, S., Glitz, D. A., Jolkovsky, L., et al. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00252-3 · Cited by 401
Self-citationA Double-Blind, Placebo-Controlled Study of Memantine in the Treatment of Major Depression
Zarate, C. A., Singh, J. B., Quiroz, J. A., De Jesus, G., Denicoff, K. K., Luckenbaugh, D. A., Manji, H. K., & Charney, D. S. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.153 · Cited by 387
Self-citationGlycogen Synthase Kinase-3: a Putative Molecular Target for Lithium Mimetic Drugs
Gould, T. D., & Manji, H. K. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300731 · Cited by 375
Self-citationInhibition of N-acetylaspartate production: implications for 1H MRS studies in vivo
Bates, T. E., Strangward, M., Keelan, J., Davey, G. P., Munro, P. M. G., & Clark, J. B. (1996) · NeuroReport · doi:10.1097/00001756-199605310-00014 · Cited by 365
Neuropharmacology of AMPA and kainate receptors
Bleakman, D., & Lodge, D. (1998) · Neuropharmacology · doi:10.1016/s0028-3908(98)00139-7 · Cited by 363
Finding the Intracellular Signaling Pathways Affected by Mood Disorder Treatments
Coyle, J. T., & Duman, R. S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00195-8 · Cited by 360
Leverich, G. S., Altshuler, L. L., Frye, M. A., Suppes, T., Keck, P. E., McElroy, S. L., Denicoff, K. D., Obrocea, G., Nolen, W. A., Kupka, R., et al. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0503 · Cited by 352
Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels
Bormann, J. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90385-3 · Cited by 351
Pramipexole for bipolar II depression: a placebo-controlled proof of concept study
Zarate, C. A., Payne, J. L., Singh, J., Quiroz, J. A., Luckenbaugh, D. A., Denicoff, K. D., Charney, D. S., & Manji, H. K. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.03.013 · Cited by 347
Self-citationHypothalamic-pituitary-adrenal axis function in patients with bipolar disorder
Watson, S., Gallagher, P., Ritchie, J. C., Ferrier, I. N., & Young, A. H. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.184.6.496 · Cited by 343
Neuroplasticity and cellular resilience in mood disorders
Manji, H. K., Moore, G. J., Rajkowska, G., & Chen, G. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000811 · Cited by 340
Self-citationHistone deacetylase inhibitors
Monneret, C. (2005) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2004.10.001 · Cited by 338
Hippocampal Remodeling and Damage by Corticosteroids Implications for Mood Disorders
Brown, E. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00054-8 · Cited by 335
Martinez, A., Castro, A., Dorronsoro, I., & Alonso, M. (2002) · Medicinal Research Reviews · doi:10.1002/med.10011 · Cited by 333
Manji, H. K., MD, Duman, F. A. R. S., & PhD (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4260 · Cited by 330
Self-citationAn Open-Label Trial of Riluzole in Patients With Treatment-Resistant Major Depression
Zarate, C. A., Payne, J. L., Quiroz, J., Sporn, J., Denicoff, K. K., Luckenbaugh, D., Charney, D. S., & Manji, H. K. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.1.171 · Cited by 324
Self-citationAn open label trial of C-1073 (mifepristone) for psychotic major depression*
Belanoff, J. K., Rothschild, A. J., Cassidy, F., DeBattista, C., Baulieu, E.-E., Schold, C., & Schatzberg, A. F. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01432-4 · Cited by 320
Protein kinase C overactivity impairs prefrontal cortical regulation of working memory
Birnbaum, S. G., Yuan, P. X., Wang, M., Vijayraghavan, S., Bloom, A. K., Davis, D. J., Gobeske, K. T., Sweatt, J. D., Manji, H. K., & Arnsten, A. F. T. (2004) · Science · doi:10.1126/science.1100021 · Cited by 318
Self-citationYoung, A. H., Gallagher, P., Watson, S., Del-Estal, D., Owen, B. M., & Nicol Ferrier, I. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300471 · Cited by 318
Tatarczyńska, E., Kłodzińska, A., Chojnacka‐Wójcik, E., Pałucha, A., Gasparini, F., Kuhn, R., & Pilc, A. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703923 · Cited by 314
Phenylglycine derivatives as antagonists of metabotropic glutamate receptors
Watkins, J. C., & Collingridge, G. L. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90028-0 · Cited by 305
Ochs, G., Penn, R. D., York, M., Giess, R., Beck, M., Tonn, J., Haigh, J., Malta, E., Traub, M., Sendtner, M., et al. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/14660820050515197 · Cited by 302
Critical loss of CBP/p300 histone acetylase activity by caspase‐6 during neurodegeneration
Rouaux, C., Jokic, N., Mbebi, C., Boutillier, S., Loeffler, J., & Boutillier, A. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg615 · Cited by 302
Lauterborn, J. C., Lynch, G., Vanderklish, P., Arai, A., & Gall, C. M. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-01-00008.2000 · Cited by 290
Chen, H. S., & Lipton, S. A. (1997) · The Journal of Physiology · doi:10.1113/jphysiol.1997.sp021909 · Cited by 282
Spooren, W. P. J. M., Vassout, A., Neijt, H. C., Kuhn, R., Gasparini, F., Roux, S., Porsolt, R. D., & Gentsch, C. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39029-9 · Cited by 266
Tremolizzo, L., Doueiri, M.-S., Dong, E., Grayson, D. R., Davis, J., Pinna, G., Tueting, P., Rodriguez-Menendez, V., Costa, E., & Guidotti, A. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.046 · Cited by 258
Dehydroepiandrosterone Monotherapy in Midlife-Onset Major and Minor Depression
Schmidt, P. J., Daly, R. C., Bloch, M., Smith, M. J., Danaceau, M. A., Simpson St. Clair, L., Murphy, J. H., Haq, N., & Rubinow, D. R. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.2.154 · Cited by 254
Manji, H. K., & Lenox, R. H. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00235-8 · Cited by 241
Self-citationGould, T. D., Quiroz, J. A., Singh, J., Zarate, C. A., & Manji, H. K. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001518 · Cited by 238
Self-citationGriebel, G., Simiand, J., Steinberg, R., Jung, M., Gully, D., Roger, P., Geslin, M., Scatton, B., Maffrand, J.-P., & Soubrié, P. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.1.333 · Cited by 238
Ducottet, C., Griebel, G., & Belzung, C. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(03)00051-4 · Cited by 236
Antidepressant-like actions of an AMPA receptor potentiator (LY392098)
Li, X., Tizzano, J. P., Griffey, K., Clay, M., Lindstrom, T., & Skolnick, P. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(00)00194-5 · Cited by 225
The origin of schizophrenia: genetic thesis, epigenetic antithesis, and resolving synthesis
Petronis, A. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.02.005 · Cited by 225
In Vivo Evidence in the Brain for Lithium Inhibition of Glycogen Synthase Kinase-3
Gould, T. D., Chen, G., & Manji, H. K. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300283 · Cited by 217
Self-citationRiluzole Enhances Glutamate Uptake in Rat Astrocyte Cultures
Frizzo, M. E. D. S., Dall'Onder, L. P., Dalcin, K. B., & Souza, D. O. (2004) · Cellular and Molecular Neurobiology · doi:10.1023/b:cemn.0000012717.37839.07 · Cited by 212
Functional impairment in the remission phase of bipolar disorder
Fagiolini, A., Kupfer, D. J., Masalehdan, A., Scott, J. A., Houck, P. R., & Frank, E. (2005) · Bipolar Disorders · doi:10.1111/j.1399-5618.2005.00207.x · Cited by 206
Chen, H.-S. V., Wang, Y. F., Rayudu, P. V., Edgecomb, P., Neill, J. C., Segal, M. M., Lipton, S. A., & Jensen, F. E. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00163-8 · Cited by 202
Cell pathology in bipolar disorder
Rajkowska, G. (2002) · Bipolar Disorders · doi:10.1034/j.1399-5618.2002.01149.x · Cited by 201
Update on the therapeutic potential of PDE4 inhibitors
Montana, J. G., & Dyke, H. J. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.1.1 · Cited by 196
Antidepressant-like effects of CP-154,526, a selective CRF1 receptor antagonist
Mansbach, R. S., Brooks, E. N., & Chen, Y. L. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)00025-3 · Cited by 195
Association of valproate‐induced teratogenesis with histone deacetylase inhibition in vivo
Gurvich, N., Berman, M. G., Wittner, B. S., Gentleman, R. C., Klein, P. S., & Green, J. B. A. (2005) · The FASEB Journal · doi:10.1096/fj.04-3425fje · Cited by 191
Is impaired neurogenesis relevant to the affective symptoms of depression?
Sapolsky, R. M. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.04.012 · Cited by 188
Metyrapone as Additive Treatment in Major Depression: A Double-blind and Placebo-Controlled Trial
Jahn, H., Schick, M., Kiefer, F., Kellner, M., Yassouridis, A., & Wiedemann, K. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.12.1235 · Cited by 184
Divalproex in the treatment of bipolar depression: a placebo-controlled study
Davis, L. L., Bartolucci, A., & Petty, F. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2004.09.009 · Cited by 181
Takahashi, M., Terwilliger, R., Lane, C., Mezes, P. S., Conti, M., & Duman, R. S. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-02-00610.1999 · Cited by 176
The Wnt Signaling Pathway in Bipolar Disorder
Gould, T. D., & Manji, H. K. (2002) · The Neuroscientist · doi:10.1177/107385802237176 · Cited by 174
Self-citationBlack, M. D. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2065-6 · Cited by 174
Rogóż, Z., Skuza, G., Maj, J., & Danysz, W. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00055-2 · Cited by 169
Langley, B., Gensert, J., Beal, M., & Ratan, R. (2005) · Current Drug Target -CNS & Neurological Disorders · doi:10.2174/1568007053005091 · Cited by 168
Okuyama, S., Chaki, S., Kawashima, N., Suzuki, Y., Ogawa, S., Nakazato, A., Kumagai, T., Okubo, T., & Tomisawa, K. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38220-5 · Cited by 166
Cellular Plasticity Cascades: Genes-To-Behavior Pathways in Animal Models of Bipolar Disorder
Einat, H., & Manji, H. K. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.11.004 · Cited by 166
Self-citationGould, T. D., Zarate, C. A., & Manji, H. K. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0103 · Cited by 159
Self-citationSocial stress exacerbates stroke outcome by suppressing Bcl-2 expression
DeVries, A. C., Joh, H.-D., Bernard, O., Hattori, K., Hurn, P. D., Traystman, R. J., & Alkayed, N. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.201215298 · Cited by 158
Potential Antidepressive Properties of Amantadine, Memantine and Bifemelane
Moryl, E., Danysz, W., & Quack, G. (1993) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1993.tb01351.x · Cited by 156
Antidepressant activity of memory-enhancing drugs in the reduction of submissive behavior model
Knapp, R. J., Goldenberg, R., Shuck, C., Cecil, A., Watkins, J. B., Miller, C., Crites, G. J., & Malatyńska, E. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01338-9 · Cited by 153
A Preliminary Investigation of a Protein Kinase C Inhibitor in the Treatment of Acute Mania
Bebchuk, J. M., Arfken, C. L., Manji, S., Murphy, J., Hasanat, K., & Manji, H. K. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.1.95 · Cited by 152
Self-citationMizuta, I., Ohta, M., Ohta, K., Nishimura, M., Mizuta, E., & Kuno, S. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02098-5 · Cited by 145 · cited 1×
“Recent studies have shown that riluzole stimulates the synthesis of growth factors including BDNF in cultured mouse astrocytes (Mizuta et al 2001).”
BackgroundBai, F., Bergeron, M., & Nelson, D. L. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00104-7 · Cited by 144 · cited 1×
“The antidepressant-like activity of ARPs in animals may be attributed, at least in part, to the regulation of cell proliferation in the hippocampus (Bai et al 2003).”
BackgroundKunzel, H. E., Zobel, A. W., Nickel, T., Ackl, N., Uhr, M., Sonntag, A., Ising, M., & Holsboer, F. (2003) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(03)00070-0 · Cited by 142
Mood stabilizers, glycogen synthase kinase-3β and cell survival
Jope, R. S., & Bijur, G. N. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001017 · Cited by 141
Current perspectives on the development of non-biogenic amine-based antidepressants
Skolnick, P., Legutko, B., Li, X., & Bymaster, F. P. (2001) · Pharmacological Research · doi:10.1006/phrs.2000.0806 · Cited by 140
Pałucha-Poniewiera, A., Tatarczynska, E., Brański, P., Szewczyk, B., Wierońska, J. M., Kłak, K., Chojnacka-Wójcik, E., Nowak, G., & Pilc, A. (2003) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.09.006 · Cited by 136
Glycogen Synthase Kinase 3: A Target for Novel Mood Disorder Treatments
Gould, T. D., & Manji, H. K. (2006) · Wiley eBooks · doi:10.1002/0470052171.ch7 · Cited by 134
Self-citationChronic Elevation of Brain-Derived Neurotrophic Factor by Ampakines
Lauterborn, J. C., Truong, G. S., Baudry, M., Bi, X., LYNCH, G. S., & Gall, C. M. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.053694 · Cited by 132
Chapter 11 AMPA receptors: Molecular and functional diversity
Borges, K., & Dingledine, R. J. (1998) · Progress in brain research · doi:10.1016/s0079-6123(08)60436-7 · Cited by 130
Ikeda, S. R., Lovinger, D., McCool, B., & Lewis, D. (1995) · Neuron · doi:10.1016/0896-6273(95)90341-0 · Cited by 129
Chávez-Blanco, A. D., Segura-Pacheco, B. A., Pérez‐Cárdenas, E., Taja‐Chayeb, L., Cetina, L., Candelaria, M., de León, D. F. C., González‐Fierro, A., García‐López, P., Zambrano, P., et al. (2005) · Molecular Cancer · doi:10.1186/1476-4598-4-22 · Cited by 129
Kato, T., Iwamoto, K., Kakiuchi, C., Kuratomi, G., & Okazaki, Y. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001662 · Cited by 128
Dexamethasone for the treatment of depression: a randomized, placebo- controlled, double-blind trial
Arana, G. W., Santos, A. B., Laraia, M. T., McLeod-Bryant, S., Beale, M. D., Rames, L. J., Roberts, J. M., Dias, J. K., & Molloy, M. A. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.2.265 · Cited by 125
The Pharmacology of CP‐154,526, a Non‐Peptide Antagonist of the CRH1 Receptor: A Review
Seymour, P. A., Schmidt, A. W., & Schulz, D. W. (2003) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2003.tb00244.x · Cited by 118
COYLE, J. T., & Schwarcz, R. M. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.1.90 · Cited by 111
Zarate, C. A., Quiroz, J. A., Quiroz, J. A., Manji, H. K., Payne, J. L., Kornstein, S. G., Manji, A. H. K., & MD (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4204 · Cited by 105
Self-citationPotential new medical therapies for diabetic retinopathy: protein kinase C inhibitors
Frank, R. N. (2002) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(02)01321-1 · Cited by 104
Wachtel, H., & Schneider, H. (1986) · Neuropharmacology · doi:10.1016/0028-3908(86)90159-0 · Cited by 104
NMDA and quisqualate reduce a Ca-dependent K+ current by a protein kinase-mediated mechanism
Baskys, A., Bernstein, N. K., Barolet, A. W., & Carlen, P. L. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90325-4 · Cited by 99
Glutamate receptor ligands as anxiolytics.
Chojnacka-Wójcik, E., Kłodzińska, A., & Pilc, A. (2001) · PubMed · Cited by 99
Tatarczynska, E., Kłodzińska, A., Kroczka, B., Chojnacka-Wójcik, E., & Pilc, A. (2001) · Psychopharmacology · doi:10.1007/s002130100798 · Cited by 92
Hippocampal Volume Measurement in Older Adults With Bipolar Disorder
Beyer, J. L., Kuchibhatla, M. N., Payne, M. E., Moo‐Young, M., Cassidy, F., MacFall, J. R., & Krishnan, K. R. R. (2004) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200411000-00007 · Cited by 89
Group I and Group III metabotropic glutamate receptor subtypes provide enhanced neuroprotection
Maiese, K., Vincent, A. M., Lin, S., & Shaw, T. (2000) · Journal of Neuroscience Research · doi:10.1002/1097-4547(20001015)62:2<257::aid-jnr10>3.0.co;2-h · Cited by 80
Bipolar Disorder and Health-Related Quality of Life: Review of Burden of Disease and Clinical Trials
Revicki, D. A., Matza, L. S., Flood, E. M., & Lloyd, A. R. (2005) · PharmacoEconomics · doi:10.2165/00019053-200523060-00005 · Cited by 80
Emerging experimental therapeutics for bipolar disorder: clues from the molecular pathophysiology
Quiroz, J. A., Singh, J. B., Gould, T. D., Denicoff, K. D., Zarate, C. A., & Manji, H. K. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001521 · Cited by 75
Self-citationPresynaptic inhibition of excitatory neurotransmission by lamotrigine in the rat amygdalar neurons
Wang, S., Huang, C., Hsu, K., Tsai, J., & Gean, P. (1996) · Synapse · Cited by 65
Gould, T. D., Gray, N. A., & Manji, H. K. (2003) · Pharmacological Research · doi:10.1016/s1043-6618(03)00096-3 · Cited by 64
Self-citationLi, Y.-W., Hill, G. R., Wong, H. H., Kelly, N., Ward, K., Pierdomenico, M., Ren, S. X., Gilligan, P. J., Grossman, S. J., Trainor, G. L., et al. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.045914 · Cited by 63
Gallagher, P., Watson, S., Smith, M. S., Ferrier, I. N., & Young, A. H. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.017 · Cited by 61
Inhibitors of glycogen synthase kinase-3: future therapy for unmet medical needs?
Dorronsoro, I., Castro, A., & Martínez, A. (2002) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.12.10.1527 · Cited by 57
Sarro, G. D., Siniscalchi, A., Ferreri, G., Gallelli, L., & Sarro, A. D. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00709-3 · Cited by 51
Neuroprotective effects of antidepressant and mood stabilizing drugs
Young, L. T. (2002) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0201 · Cited by 47
Tan, Y., Hori, N., & Carpenter, D. O. (2003) · Cellular and Molecular Neurobiology · doi:10.1023/a:1022949922364 · Cited by 45
Takata, K., Kitamura, Y., Kakimura, J., Kohno, Y., & Taniguchi, T. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02493-8 · Cited by 42
Harro, J., Tõnissaar, M., & Eller, M. M. (2001) · Neuropeptides · doi:10.1054/npep.2001.0851 · Cited by 41
The emerging differential roles of GABAergic and antiglutamatergic agents in bipolar disorders.
Ketter, T. A., & Wang, P. W. (2003) · PubMed · Cited by 40
Calabresi, P., Siniscalchi, A., Pisani, A., Stefani, A., Mercuri, N. B., & Bernardi, G. (1996) · Neurology · doi:10.1212/wnl.47.2.557 · Cited by 36
Young, L. T., Wang, J., Woods, C. M., & Robb, J. C. (1999) · Neuropsychobiology · doi:10.1159/000026598 · Cited by 28
Antagonists of the Corticotropin Releasing Factor Receptor
Saunders, J., & Williams, J. (2003) · Progress in medicinal chemistry · doi:10.1016/s0079-6468(02)41006-5 · Cited by 25
Collingridge, G. L. (1994) · Nature · doi:10.1038/371652a0 · Cited by 25
Salińska, E., & Stafiej, A. (2003) · Neurochemistry International · doi:10.1016/s0197-0186(03)00036-6 · Cited by 23
Cited by
Diazgranados, N., Ibrahim, L., Brutsche, N. E., Newberg, A., Kronstein, P., Khalife, S., Kammerer, W. A., Quezado, Z., Luckenbaugh, D. A., Salvadore, G., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.90 · Cited by 963
Self-citationDuman, R. S., & Voleti, B. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2011.11.004 · Cited by 714
Antidepressant-Like Effects of the Histone Deacetylase Inhibitor, Sodium Butyrate, in the Mouse
Schroeder, F. A., Lin, C. L., Crusio, W. E., & Akbarian, S. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.06.036 · Cited by 541
Signaling pathways underlying the rapid antidepressant actions of ketamine
Duman, R. S., Li, N., Liu, R.-J., Duric, V., & Aghajanian, G. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.08.044 · Cited by 537
Metadata
- Authors
- Zarate, C. A., Singh, J., & Manji, H. K.
- Venue
- Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2006-06
- Volume
- 59
- Issue
- 11
- Pages
- 1006-1020
- ISSN
- 0006-3223 (ISSN-L)
- OpenAlex
- W1978265841
- Cited by
- 274
- References
- 151
- FWCI
- 14.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.